Viz.ai partners with Bristol Myers Squibb to enable earlier detection of HCM
Viz.ai, an artificial intelligence (AI) powered disease detection and care coordination platform, has forged a multi-year agreement with Bristol Myers Squibb to enable earlier detection and management of